- Home
- BABA vs NVS Comparison
BABA vs NVS Comparison
Compare BABA & NVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BABA
- NVS
- Stock Information
- Founded
- BABA 1999
- NVS 1895
- Country
- BABA China
- NVS Switzerland
- Employees
- BABA N/A
- NVS N/A
- Industry
- BABA Business Services
- NVS Biotechnology: Pharmaceutical Preparations
- Sector
- BABA Consumer Discretionary
- NVS Health Care
- Exchange
- BABA Nasdaq
- NVS Nasdaq
- Market Cap
- BABA 205.2B
- NVS 230.5B
- IPO Year
- BABA 2014
- NVS 1991
- Fundamental
- Price
- BABA $82.36
- NVS $97.08
- Analyst Decision
- BABA Strong Buy
- NVS Hold
- Analyst Count
- BABA 15
- NVS 6
- Target Price
- BABA $111.86
- NVS $121.25
- AVG Volume (30 Days)
- BABA 14.4M
- NVS 1.1M
- Earning Date
- BABA 02-05-2025
- NVS 01-31-2025
- Dividend Yield
- BABA 1.22%
- NVS 3.89%
- EPS Growth
- BABA N/A
- NVS 130.53
- EPS
- BABA 4.94
- NVS 8.58
- Revenue
- BABA $137,138,926,320.00
- NVS $49,940,000,000.00
- Revenue This Year
- BABA $8.41
- NVS $10.04
- Revenue Next Year
- BABA $8.88
- NVS $4.55
- P/E Ratio
- BABA $17.08
- NVS $11.02
- Revenue Growth
- BABA 5.14
- NVS 8.92
- 52 Week Low
- BABA $66.63
- NVS $92.35
- 52 Week High
- BABA $117.82
- NVS $120.92
- Technical
- Relative Strength Index (RSI)
- BABA 36.33
- NVS 27.93
- Support Level
- BABA $88.00
- NVS $97.69
- Resistance Level
- BABA $87.60
- NVS $99.67
- Average True Range (ATR)
- BABA 1.44
- NVS 1.01
- MACD
- BABA -0.06
- NVS -0.18
- Stochastic Oscillator
- BABA 5.31
- NVS 10.97
About BABA Alibaba Group Holding Limited
Alibaba is the world's largest online and mobile commerce company as measured by gross merchandise volume. It operates China's online marketplaces, including Taobao (consumer-to-consumer) and Tmall (business-to-consumer). The China commerce retail division is the most valuable cash flow-generating business at Alibaba. Additional revenue sources include China commerce wholesale, international commerce retail/wholesale, local consumer services, cloud computing, digital media and entertainment platforms, Cainiao logistics services, and innovation initiatives/other.
About NVS Novartis AG
Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.